文献速递肺血管病与心包/心肌炎

MicroRNA-124通过PTBP1与丙酮酸激酶M2调控肺动脉高压内皮细胞糖酵解增强

Identification of MicroRNA-124 as a Major Regulator of Enhanced Endothelial Cell Glycolysis in Pulmonary Arterial Hypertension via PTBP1 (Polypyrimidine Tract Binding Protein) and Pyruvate Kinase M2.
PubMed 文献 · Circulation · 2017-09-26

该研究探讨肺动脉高压(PAH)内皮细胞糖酵解增强的机制,发现遗传性PAH和特发性PAH患者血源性内皮细胞(BOEC)中miR-124下调,导致PTBP1上调并促进PKM2表达,从而增强糖酵解和增殖。过表达miR-124或沉默PTBP1可恢复正常的增殖和糖酵解,提示该通路是潜在治疗靶点。

要点

  • PAH患者BOEC中miR-124下调,PTBP1和PKM2表达增加,糖酵解增强。
  • 过表达miR-124或沉默PTBP1可逆转PAH内皮细胞的异常增殖和糖酵解。
  • BMPR2敲低可降低miR-124、增加PTBP1并增强糖酵解,大鼠PAH模型验证该机制。

核心结论

  • PAH患者肺动脉血管及循环祖内皮细胞中miR-124下调,通过PTBP1和PKM1/PKM2导致代谢和增殖异常。
  • 调控该miRNA或其靶点可能成为PAH治疗新策略。

研究设计与样本

  • 研究比较遗传性PAH(BMPR2突变)和特发性PAH患者的血源性内皮细胞(BOEC)的miRNA和蛋白质组谱。
  • 采用分层系统生物学方法鉴定miR-124下调,并在大鼠SUGEN-缺氧PAH模型中验证。

主要发现

  • 遗传性和特发性PAH的BOEC重现了特发性PAH患者肺动脉内皮细胞的代谢异常,证实从氧化磷酸化向有氧糖酵解的转换。
  • 过表达miR-124或siRNA沉默PTBP1可恢复遗传性PAH BOEC的正常增殖和糖酵解,纠正糖酵解基因失调和乳酸生成,并部分恢复线粒体呼吸。
  • 对照BOEC中敲低BMPR2可降低miR-124表达、增加PTBP1并增强糖酵解。
  • 大鼠SUGEN-缺氧重度PAH模型中观察到miR-124降低、PTBP1和PKM2表达增加及糖酵解基因显著失调,支持该机制的体内相关性。

临床怎么用

  • PAH内皮细胞的代谢重编程与miR-124-PTBP1-PKM2轴相关,可能作为生物标志物或治疗靶点。
  • 调节miR-124或其下游靶点有望纠正PAH内皮细胞的异常糖酵解和增殖。

局限性

  • 研究主要基于体外BOEC和大鼠模型,尚未在人体临床试验中验证。
  • 原文未明确报告样本量、具体数值和统计显著性指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pulmonary arterial hypertension (PAH) is characterized by abnormal growth and enhanced glycolysis of pulmonary artery endothelial cells. However, the mechanisms underlying alterations in energy production have not been identified. METHODS: Here, we examined the miRNA and proteomic profiles of blood outgrowth endothelial cells (BOECs) from patients with heritable PAH caused by mutations in the bone morphogenetic protein receptor type 2 (BMPR2) gene and patients with idiopathic PAH to determine mechanisms underlying abnormal endothelial glycolysis. We hypothesized that in BOECs from patients with PAH, the downregulation of microRNA-124 (miR-124), determined with a tiered systems biology approach, is responsible for increased expression of the splicing factor PTBP1 (polypyrimidine tract binding protein), resulting in alternative splicing of pyruvate kinase muscle isoforms 1 and 2 (PKM1 and 2) and consequently increased PKM2 expression. We questioned whether this alternative regulation plays a critical role in the hyperglycolytic phenotype of PAH endothelial cells. RESULTS: Heritable PAH and idiopathic PAH BOECs recapitulated the metabolic abnormalities observed in pulmonary artery endothelial cells from patients with idiopathic PAH, confirming a switch from oxidative phosphorylation to aerobic glycolysis. Overexpression of miR-124 or siRNA silencing of PTPB1 restored normal proliferation and glycolysis in heritable PAH BOECs, corrected the dysregulation of glycolytic genes and lactate production, and partially restored mitochondrial respiration. BMPR2 knockdown in control BOECs reduced the expression of miR-124, increased PTPB1, and enhanced glycolysis. Moreover, we observed reduced miR-124, increased PTPB1 and PKM2 expression, and significant dysregulation of glycolytic genes in the rat SUGEN-hypoxia model of severe PAH, characterized by reduced BMPR2 expression and endothelial hyperproliferation, supporting the relevance of this mechanism in vivo. CONCLUSIONS: Pulmonary vascular and circulating progenitor endothelial cells isolated from patients with PAH demonstrate downregulation of miR-124, leading to the metabolic and proliferative abnormalities in PAH ECs via PTPB1 and PKM1/PKM2. Therefore, the manipulation of this miRNA or its targets could represent a novel therapeutic approach for the treatment of PAH.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Caruso P, Dunmore BJ, Schlosser K, et al. Identification of MicroRNA-124 as a Major Regulator of Enhanced Endothelial Cell Glycolysis in Pulmonary Arterial Hypertension via PTBP1 (Polypyrimidine Tract Binding Protein) and Pyruvate Kinase M2. Circulation. 2017. PMID: 28971999. doi:10.1161/CIRCULATIONAHA.117.028034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。